Showing results (1851-1860 of 2,026) with videos related to
Sort By:
Pageof 203
Urologic Oncology|October 22, 2016
Phase 1/2 multiple ascending dose trial of the prostate-specific membrane antigen-targeted antibody drug conjugate MLN2704 in metastatic castration-resistant prostate cancerMatthew I Milowsky, Matthew D Galsky, Michael J Morris, et al.Microbial Ecology|October 1, 2024
Subsurface Microbial Colonization at Mineral-Filled Veins in 2-Billion-Year-Old Mafic Rock from the Bushveld Igneous Complex, South AfricaYohey Suzuki, Susan J Webb, Mariko Kouduka, et al.Molecular Therapy Oncolytics|June 14, 2023
Trap and ambush therapy using sequential primary and tumor escape-selective oncolytic virusesMason J Webb, Timothy Kottke, Benjamin L Kendall, et al.The Lancet. Rheumatology|October 5, 2020
Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort studyBrandon J Webb, Ithan D Peltan, Paul Jensen, et al.Journal of Intensive Care Medicine|August 7, 2024
Droxidopa for Vasopressor Weaning in Critically Ill Patients with Persistent Hypotension: A Multicenter, Retrospective, Single-Arm Observational StudyAndrew J Webb, Gianna Lh Casal, Kelly A Newman, et al.Open Forum Infectious Diseases|July 30, 2021
Real-world Effectiveness and Tolerability of Monoclonal Antibody Therapy for Ambulatory Patients With Early COVID-19Brandon J Webb, Whitney Buckel, Todd Vento, et al.Nature Ecology & Evolution|September 24, 2021
Refocusing multiple stressor research around the targets and scales of ecological impactsBenno I Simmons, Penelope S A Blyth, Julia L Blanchard, et al.AMIA ... Annual Symposium Proceedings. AMIA Symposium|April 21, 2020
Implementation of Real-Time Electronic Clinical Decision Support for Emergency Department Patients with Pneumonia Across a Healthcare SystemNathan C Dean, Caroline G Vines, Jenna Rubin, et al.The Lancet. Diabetes & Endocrinology|April 16, 2018
Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudiesBryan Williams, Thomas M MacDonald, Steve V Morant, et al.Frontiers in Immunology|March 29, 2021
Soluble Sema4D in Plasma of Head and Neck Squamous Cell Carcinoma Patients Is Associated With Underlying Non-Inflamed Tumor ProfileRania H Younis, Ioana Ghita, Manar Elnaggar, et al.Pageof 203